FAST NEWS: JW Therapeutics to expand collaboration with 2Seventy Bio
The latest: Drug maker JW (Cayman) Therapeutics Co. Ltd. (2126.HK) said on Tuesday it is in talks to expand its strategic alliance with 2Seventy Bio (TSVT.US), which began with a partnership established in…
Recent Articles
RELATED ARTICLES
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK - Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
- IPO pitch puts BrainAurora’s earnings under the microscope
-
A blockbuster cancer drug? TYK’s claims go under the microscope
2410.HK
-
BRIEF: Qyuns Therapeutics secures CSRC approval for full H-share circulation
2509.HK
